ClinicalTrials.Veeva

Menu

Impact of Consuming a Plant-based Enriched Meal on the Adult Gut Microbiome

N

Nestlé

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: plant based preparation
Dietary Supplement: oat based porridge

Study type

Interventional

Funder types

Industry

Identifiers

NCT05459662
2106NRC2

Details and patient eligibility

About

The aim of this study is to evaluate the impact of a diversified plant-based meal on the gut microbiome and its composition.

Enrollment

26 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-55 years,
  • Healthy participants, both male and female,
  • BMI in the normal and overweight range 18.5 ≤ BMI ≤ 29.9 kg/m2,
  • Able to understand and to sign a written informed consent prior to study enrolment.

Exclusion criteria

  • Known chronic diseases or conditions for which the investigators/investigation team deem as not suitable for study participation,
  • Known food allergy and intolerance e.g. lactose intolerance, nuts allergy,
  • Habitually, have < 5 spontaneous bowel movements on average per week,
  • Chronic or recurrent diarrhoea with spontaneous bowel movements > 2 per day
  • Prior gastrointestinal surgery (apart from appendectomy or herniotomy),
  • Received systemic antiviral/antibacterial/antifungal therapy during the 3 months prior to study enrolment,
  • Medications or supplements that are known to alter gut function or microflora i.e. acid antisecretory drugs, pre-/probiotics, laxative during the 4 weeks prior to study enrolment,
  • Anti-hyperlipidaemic, antihypertensive medications and/or anticoagulant agents,
  • Currently participating in another interventional clinical trial or research project,
  • Alcohol intake > 2 servings per day; specifically, a serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer. Or other chronic substance abuse,
  • Changing diet patterns due to travelling and staying abroad for more than two weeks (Asia, Africa, or Latin America) during the two months prior to study enrolment,
  • Food restrictions such as vegan, vegetarian, ketogenic, low carb, paleo, raw diets, caloric restrictive diets,
  • Artificially sweetened beverage intake >1000 ml/ per day,
  • Female participants will be excluded if they are pregnant, have given birth in the last 6 months, or are lactating,
  • Subject having a hierarchical or family link with the research team members,
  • Occurrence of fever episodes, infection, or vaccination during 14 days before the start of the study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

26 participants in 2 patient groups, including a placebo group

Oat based porridge
Placebo Comparator group
Description:
Oat based porridge prepared with 64g of oat, 200ml of milk and 10 g of honey by the participant and consumed orally daily for 14 days as breakfast replacement
Treatment:
Dietary Supplement: oat based porridge
Enriched plant-based meal
Active Comparator group
Description:
Enriched plant-based meal pots (400 g) mixed with 25g of seeds and nuts consumed orally daily for 14 days as breakfast replacement
Treatment:
Dietary Supplement: plant based preparation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems